Can persistent innate immune activation drive microglial inflammation and Alzheimer-related damage?

Persistent innate immune activation is biologically capable of amplifying Alzheimer-relevant microglial inflammation, with convergent experimental evidence linking this state to impaired amyloid handling, greater tau pathology, and synaptic loss. The strongest causal directionality comes from cellular and transgenic mouse models; human biomarker findings are consistent with, but do not by themselves establish, the same sequence.

Inflammatory amplification and amyloid handling

• In aged APP/PS1 mice, peripheral lipopolysaccharide challenge activated microglia through an NLRP3-linked pathway, impaired amyloid-β (Aβ) clearance, and altered amyloid deposition. NLRP3 activation promotes caspase-1-dependent IL-1β and IL-18 release, potentially sustaining the inflammatory state.
• IL-1β, TNF-α, and IFN-γ can inhibit microglial uptake and lysosomal degradation of fibrillar Aβ. Lysosomal acidification defects, mitochondrial/oxidative stress, and cathepsin-B release may further activate NLRP3, creating a feed-forward loop between Aβ-associated cellular injury and impaired clearance.

Tau and synaptic mechanisms

• Evidence for inflammatory microglia increasing tau pathology is particularly strong in tauopathy models. In PS19 mice, microglial NF-κB activation increased tau seeding and spread, while microglia-specific NF-κB inactivation reduced both. Loss of NLRP3 or ASC likewise attenuated tau pathology.
• IL-1β may promote neuronal p38 MAPK and GSK-3β signaling, favoring tau phosphorylation; microglia can also facilitate seed-competent tau dissemination, including through exosome-related processes. Tau aggregates can in turn activate microglial NLRP3–ASC signaling and IL-1β release.
• Aβ oligomers activate C1q-initiated classical complement. C3 fragments tag synapses for CR3-dependent microglial engulfment; C1q, C3, or CR3 blockade/deletion reduced engulfment or early synapse loss in Alzheimer-model mice.

Bottom line

• Persistent innate immune activation is a supported upstream contributor to pathogenic microglial signaling. It is most convincingly linked experimentally to tau propagation and complement-mediated synaptic injury, while impaired Aβ clearance is mechanistically credible and supported primarily in preclinical systems.